Birdwatch Note Rating
2023-04-09 22:18:35 UTC - NOT_HELPFUL
Rated by Participant: F756BC263B83FA4E511E70DA516109809E0DCDEE917274CA91793FFD8E788424
Participant Details
Original Note:
The suspension of approval of the drug has to do with safety concerns, and the government has time to appeal the decision. "The Court does not second-guess FDA’s decision-making lightly," Kacsmaryk wrote. "But here, FDA acquiesced on its legitimate safety concerns” https://www.nbcnews.com/news/us-news/abortion-pill-case-texas-judge-halts-access-mifepristone-rcna72117
All Note Details